DE602004019697D1 - Ep2-rezeptoragonisten - Google Patents

Ep2-rezeptoragonisten

Info

Publication number
DE602004019697D1
DE602004019697D1 DE602004019697T DE602004019697T DE602004019697D1 DE 602004019697 D1 DE602004019697 D1 DE 602004019697D1 DE 602004019697 T DE602004019697 T DE 602004019697T DE 602004019697 T DE602004019697 T DE 602004019697T DE 602004019697 D1 DE602004019697 D1 DE 602004019697D1
Authority
DE
Germany
Prior art keywords
receptor agonists
sub
receptor
agonism
prodrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004019697T
Other languages
German (de)
English (en)
Inventor
Richard Anthony Borman
Robert Alexander Coleman
Kenneth Lyle Clark
Keith Mills
Alexander William Oxford
Jian Zhang
Peter Thomas Duff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asterand UK Ltd
Original Assignee
Asterand UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asterand UK Ltd filed Critical Asterand UK Ltd
Publication of DE602004019697D1 publication Critical patent/DE602004019697D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE602004019697T 2003-12-22 2004-12-22 Ep2-rezeptoragonisten Expired - Lifetime DE602004019697D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0329620.9A GB0329620D0 (en) 2003-12-22 2003-12-22 EP2 receptor agonists
US53197903P 2003-12-24 2003-12-24
US62201204P 2004-10-27 2004-10-27
PCT/GB2004/005421 WO2005061449A1 (en) 2003-12-22 2004-12-22 Ep2 receptor agonists

Publications (1)

Publication Number Publication Date
DE602004019697D1 true DE602004019697D1 (de) 2009-04-09

Family

ID=30776234

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004019697T Expired - Lifetime DE602004019697D1 (de) 2003-12-22 2004-12-22 Ep2-rezeptoragonisten

Country Status (8)

Country Link
US (2) US20050209336A1 (enExample)
EP (1) EP1716113B1 (enExample)
JP (1) JP2007515467A (enExample)
AT (1) ATE423765T1 (enExample)
DE (1) DE602004019697D1 (enExample)
ES (1) ES2322765T3 (enExample)
GB (1) GB0329620D0 (enExample)
WO (1) WO2005061449A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005080367A1 (en) 2004-02-12 2005-09-01 Pharmagene Laboratories Limited Ep2 receptor agonists
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
US8080567B2 (en) 2005-08-09 2011-12-20 Asterand Uk Limited EP2 receptor agonists
AU2007233212B2 (en) * 2006-04-04 2012-09-13 Allergan, Inc. Therapeutic prostaglandin compounds for the treatment of glaucoma
US7491844B2 (en) * 2006-05-04 2009-02-17 Allergan, Inc. Therapeutic cyclopentane derivatives
US9365485B2 (en) 2007-01-25 2016-06-14 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
US8722726B2 (en) 2007-01-25 2014-05-13 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
US7781465B2 (en) * 2007-08-21 2010-08-24 Allergan, Inc. Therapeutic oxazolidinones and thiazolidinones
BRPI0907522A2 (pt) * 2008-02-05 2019-09-24 Asterand Uk Ltd biarlamidas
LT2264009T (lt) 2008-03-12 2019-04-25 Ube Industries, Ltd. Piridilaminoacto rūgšties junginys
JP5836262B2 (ja) 2009-03-19 2015-12-24 フェイト セラピューティクス， インコーポレイテッド サイクリックａｍｐエンハンサーおよび／またはｅｐリガンドを含む組成物、ならびにこれを調製および使用する方法
PL2415763T3 (pl) 2009-03-30 2016-05-31 Ube Industries Kompozycja farmaceutyczna do leczenia lub profilaktyki jaskry
WO2011030865A1 (ja) * 2009-09-11 2011-03-17 宇部興産株式会社 置換ベンジル化合物
KR20120068902A (ko) * 2009-09-11 2012-06-27 우베 고산 가부시키가이샤 아닐린 화합물
WO2011030872A1 (ja) * 2009-09-11 2011-03-17 宇部興産株式会社 スルホンアミド化合物
WO2011030873A1 (ja) * 2009-09-11 2011-03-17 宇部興産株式会社 ベンジル化合物
WO2014031581A1 (en) 2012-08-21 2014-02-27 Allergan, Inc. Process for the synthesis of substituted gamma lactams

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5462968A (en) * 1994-01-19 1995-10-31 Allergan, Inc. EP2 -receptor agonists as agents for lowering intraocular pressure
US5576347A (en) * 1994-11-14 1996-11-19 Sredni; Benjamin Method of treating gastric ulcers
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5698598A (en) * 1995-08-04 1997-12-16 Allergan EP2 -receptor agonists as agents for lowering intraocular pressure
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6090847A (en) * 1997-11-21 2000-07-18 Allergan Sales, Inc. EP2 -receptor agonists as neuroprotective agents for the eye
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
US6437146B1 (en) * 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
SE9900025D0 (sv) * 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
EP1438104B1 (en) * 2001-10-26 2006-04-05 Allergan, Inc. Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
CN1617868A (zh) * 2001-11-05 2005-05-18 阿勒根公司 作为EP2－受体激动剂的ω－环烷基17－杂芳基前列腺素E2 类似物

Also Published As

Publication number Publication date
JP2007515467A (ja) 2007-06-14
ATE423765T1 (de) 2009-03-15
GB0329620D0 (en) 2004-01-28
US20080045596A1 (en) 2008-02-21
WO2005061449A1 (en) 2005-07-07
US20050209336A1 (en) 2005-09-22
EP1716113A1 (en) 2006-11-02
EP1716113B1 (en) 2009-02-25
ES2322765T3 (es) 2009-06-26

Similar Documents

Publication Publication Date Title
ATE423765T1 (de) Ep2-rezeptoragonisten
ATE470662T1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
UA93351C2 (uk) Похідні фталазіну як інгібітори parp
ATE302775T1 (de) Carbolinderivate
NO20041504L (no) Lactamderivater som antagonister for humane 11CBY reseptorer.
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
ATE346067T1 (de) Carbolinderivate
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
BRPI0516981A (pt) inibidores de mif
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
ATE455103T1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
EA200401455A1 (ru) Производные бензоксазина в качестве модуляторов 5-htи их применение
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
ATE308325T1 (de) Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trion derivate als metalloproteinase inhibitoren
ATE396724T1 (de) 1h-thieno 2,3-c-pyrazol-derivate als kinase-i- hemmer
EP1684442A4 (en) ECHO SUPPRESSION DEVICE
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
EA200300988A1 (ru) Производные фенил-гетероциклильных эфиров в качестве ингибиторов обратного захвата серотонина
IS8042A (is) Benz[1,2,5]thíadíazól efnasambönd
EA200300917A1 (ru) Порошковый состав
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
ATE403422T1 (de) Substituierte hydrazone als hemmer von cyclooxygenase-2
RU2006107361A (ru) Средство, обладающее гематопротекторным действием
BRPI0708098B8 (pt) derivados de 4-benzoilaminofenil)-6,7-dimetóxi-2-metilaminoquinazolina, composição farmacêutica e agente antiprurítico
FR2835436B1 (fr) Instrumentation pour analgesie, notamment peridurale

Legal Events

Date Code Title Description
8364 No opposition during term of opposition